Topical application of an Ayurvedic drug in simple Allergic Conjunctivitis

Role of Kanduhara Anjana in the management of Simple Allergic Conjunctivitis

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047477

Enrollment

Registered

2022-11-21

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Presenting with clinical features of simple allergic conjunctivitis irrespective of duration of disease. 2.Age between 5-60 years. 3.Patient willing to participate in the study by giving the informed consent. 4.Patient not having any systematic disorders like DM, HTN, CAD as well as other eye aliments.

Exclusion criteria

Exclusion criteria: 1.Patients with other severe complication. 2.Patient have other type of conjunctivitis. 3.Conjunctivitis in children’s 4.Other systemic disorder. 5.Patient having history of ocular surgery within 3 month of study will not be taken. 6.Patient who start developing complications will be excluded from the study. 7.Patient not willing for the treatment.

Design outcomes

Primary

Measure	Time frame
Reduction in Itching,Redness and SwellingTimepoint: 15 Days	—

Secondary

Measure	Time frame
Evaluate the co-relation of simple allergic conjunctivitis with Ayurvedic eye disease.Timepoint: 15 Days	—

Countries

India

Contacts

Public ContactRanjan Tyagi

BHU

bijoyananda@bhu.ac.in7905827622

Outcome results